KRISTEN WILLIAMS: Open Payments
NPI 1972027522 · TROY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 19 payments from 11 companies in 2025. Trend: 2023 $424 · 2024 $290 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $99 |
| Amgen Inc. | 3 | $42 |
| Medtronic, Inc. | 1 | $36 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Novo Nordisk Inc | 2 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Verona Pharma, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: Veozah, EVENITY, MINIMED 780G, TRELEGY ELLIPTA, GEMTESA, Ohtuvayre, VERQUVO, INSPIRE.
Industry payments across AL — which companies pay providers there.
